Camilo José Cela University
If you are the contact person for this centre and you wish to make any changes, please contact us.
Associate Professor at Camilo José Cela University, researcher at the HM Hospitales Health Research Institute (Madrid) and collaborating researcher in the Department of Personality, Evaluation and Clinical Psychology at the Complutense University of Madrid
Professor of Pharmacology and Vice-Chancellor for Research and Science at Camilo José Cela University (Madrid), and research member of the 12 de Octubre Hospital Research Institute and the HM Hospitals Health Research Institute (IISHM)
Several recent studies had concluded that the risk of gastric cancer doubled with the use of drugs such as omeprazole – proton pump inhibitors. A new study published in The BMJ states that there is no association between prolonged use of these drugs and the risk of gastric adenocarcinoma. The research used prospective data from registries in Denmark, Finland, Iceland, Norway, and Sweden between 1994 and 2020. The study included more than 17,000 patients with gastric adenocarcinoma (other than cardia cancer) who had been exposed to these drugs for more than one year.
From 2014 to 2023, one in six people in the world suffered from loneliness, according to a World Health Organisation report, which outlines the causes of this phenomenon and its multiple impacts: on physical and mental health and mortality, as well as on work and the economy. The report estimates that loneliness is linked to more than 871,000 deaths per year and highlights a higher incidence among young people and in low- and middle-income countries.
The European Medicines Agency (EMA) safety committee (PRAC) has recommended a change to the information on codeine-ibuprofen combination medicines to include "a warning about serious harm, including death, especially when taken for prolonged periods at higher than recommended doses". The PRAC reviewed several cases of renal, gastrointestinal and metabolic toxicity that had been reported in association with cases of abuse and dependence on these drugs.
A study published today in the Journal of Neurology Neurosurgery & Psychiatry claims that some drugs used to treat attention deficit hyperactivity disorder (ADHD) may also help with some symptoms of Alzheimer's disease.